These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22585655)

  • 1. Auricular pyoderma gangrenosum associated with Crohn's disease.
    Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
    Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyoderma gangrenosum in Crohn's disease].
    Baryshnikov EN; Neĭman KP
    Eksp Klin Gastroenterol; 2008; (5):92-4. PubMed ID: 19145923
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facial ulceration in a patient with Crohn's disease.
    Huang B; Melmed GY; Shih DQ
    Gastroenterology; 2012 May; 142(5):1071, 1258. PubMed ID: 22440954
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auricular pyoderma gangrenosum with penetration in a patient with rheumatoid arthritis.
    Ohashi T; Miura T; Yamamoto T
    Int J Rheum Dis; 2018 Feb; 21(2):563-565. PubMed ID: 24916772
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
    Alkhouri N; Hupertz V; Mahajan L
    Inflamm Bowel Dis; 2009 Jun; 15(6):803-6. PubMed ID: 18942748
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab for the treatment of localized pyoderma gangrenosum associated with Crohn's disease: A case report.
    Pender TM; Ayandibu G; Van Voorhees AS
    Dermatol Ther; 2020 Nov; 33(6):e14352. PubMed ID: 32981217
    [No Abstract]   [Full Text] [Related]  

  • 11. Scrotal pyoderma gangrenosum associated with Crohn's disease.
    Ho SA; Tan WP; Tan AW; Wong SN; Chua SH
    Singapore Med J; 2009 Dec; 50(12):e397-400. PubMed ID: 20087538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory pyoderma gangrenosum of the orbit and the lacrimal sac.
    Cordero-Coma M; Pérez-Moreiras JV; Toribio A; Alonso-Orcajo N; Calleja S; Franco M; Ruiz de Morales JG
    Orbit; 2012 Aug; 31(4):249-51. PubMed ID: 22571540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
    Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
    García Cámara P; Zubiri Ara ML; García López S
    Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma Gangrenosum at a Rare Site in Crohn's Disease.
    Inayat F; Hurairah A
    Clin Gastroenterol Hepatol; 2016 Jul; 14(7):e75-6. PubMed ID: 26780536
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyoderma gangrenosum as an initial presentation of Crohn's colitis.
    Mountagui A; Al-Dury S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38110340
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of pyoderma gangrenosum associated with Crohn's disease.
    Ohmori T; Yamagiwa A; Nakamura I; Nishikawa K; Saniabadi AR
    Am J Gastroenterol; 2003 Sep; 98(9):2101-2. PubMed ID: 14499797
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyoderma gangrenosum and tumor necrosis factor α agents.
    Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
    Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.